TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard‐of‐Care Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.31915
Abstract: Extrahepatic portal vein occlusion (EHPVO) from portal vein thrombosis is a rare condition associated with substantial morbidity and mortality. The purpose of this study is to investigate the efficacy of transjugular intrahepatic portosystemic shunts (TIPS)… read more here.
Keywords: venous thrombosis; refractory standard; mesenteric venous; adults without ... See more keywords
Arterial Embolization Using Microspheres for Hypervascular Liver Metastases Refractory to Standard Treatments: A Multicenter Prospective Clinical Trial
Sign Up to like & getrecommendations! Published in 2020 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02673-5
Abstract: To evaluate the clinical utility of bland arterial embolization using microspheres in patients with hypervascular liver metastases refractory to standard treatments. Primary endpoints of this prospective single-arm non-comparative study were objective response and disease control… read more here.
Keywords: refractory standard; standard treatments; embolization; metastases refractory ... See more keywords
Phase 1 trial of OCV-C02, a peptide vaccine for metastatic colorectal cancer patients refractory to all standard chemotherapies.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.4_suppl.706
Abstract: 706Background: OCV-C02 is a peptide vaccine consisting of 2 peptide epitopes derived from ring finger protein 43 and translocase of outer mitochondrial membrane 34. In colorectal cancer (CRC), they are upregulated in approximately 80% of… read more here.
Keywords: refractory standard; colorectal cancer; ocv c02; peptide vaccine ... See more keywords